Filing Flows

Filing Flows › Keros Therapeutics (KROS) › Who owns the stock

Who owns Keros Therapeutics (KROS) stock

130 funds reported Keros Therapeutics (KROS) shares in their latest 13F filings, worth $244M in all. The largest holder is Vanguard Group ($31.1M). Last quarter 56 funds added to their stakes and 72 cut them.

Largest holders of KROS (13F)Largest holders of KROS (13F)Vanguard Group$31.1MNantahala Capital Management, LLC$30.2MBlackRock$29.9MAQR Capital Management LLC$10.4MVanguard Capital Management LLC$8.9MMackenzie Financial$8.5MOrbimed Advisors LLC$8.1MFederated Hermes$7.5MVanguard Portfolio Management LLC$7.0MMadison Avenue Partners, LP$6.7M

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group1,525,355$31.1Mdecrease2025-12-31
Nantahala Capital Management, LLC2,820,838$30.2Mincrease2026-06-30
BlackRock2,794,217$29.9Mincrease2026-06-30
AQR Capital Management LLC967,859$10.4Mincrease2026-06-30
Vanguard Capital Management LLC833,596$8.9Mincrease2026-06-30
Mackenzie Financial742,837$8.5Mincrease2026-09-30
Orbimed Advisors LLC759,155$8.1Munchanged2026-06-30
Federated Hermes700,427$7.5Mincrease2026-06-30
Vanguard Portfolio Management LLC652,635$7.0Mdecrease2026-06-30
Madison Avenue Partners, LP626,583$6.7Munchanged2026-06-30
Qube Research & Technologies608,837$6.5Mdecrease2026-06-30
Jacobs Levy Equity Management605,445$6.5Mdecrease2026-06-30
State Street541,193$5.8Mdecrease2026-06-30
Geode Capital Management, LLC510,841$5.5Mdecrease2026-06-30
Dimensional Fund Advisors LP460,541$4.9Mincrease2026-06-30

Keros Therapeutics' latest quarter

Keros Therapeutics, Q3 2026: revenue $40.0M (+183% year over year), operating margin 32.0%, net earnings $14.2M, operating cash flow $3.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most KROS stock?

By the latest 13F filings: Vanguard Group ($31.1M); Nantahala Capital Management, LLC ($30.2M); BlackRock ($29.9M); AQR Capital Management LLC ($10.4M); Vanguard Capital Management LLC ($8.9M).

What is the short interest in KROS?

1,136,901 shares were sold short at the 2026-10-15 settlement, -1.09% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.